Magee, LA;
Molteni, E;
Bowyer, V;
Bone, JN;
Boulding, H;
Khalil, A;
Mistry, HD;
Poston, L;
Silverio, SA;
Wolfe, I;
et al.
Magee, LA; Molteni, E; Bowyer, V; Bone, JN; Boulding, H; Khalil, A; Mistry, HD; Poston, L; Silverio, SA; Wolfe, I; Duncan, EL; von Dadelszen, P; RESILIENT Study Group
(2023)
National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age.
Nat Commun, 14 (1).
p. 956.
ISSN 2041-1723
https://doi.org/10.1038/s41467-023-36125-8
SGUL Authors: Khalil, Asma
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
|
|
PDF (Supplementary Information)
Published Version
Available under License Creative Commons Attribution. Download (563kB) | Preview |
|
|
PDF (Reporting Summary)
Published Version
Available under License Creative Commons Attribution. Download (72kB) | Preview |
Abstract
Women of reproductive age are a group of particular concern with regards to vaccine uptake, related to their unique considerations of menstruation, fertility, and pregnancy. To obtain vaccine uptake data specific to this group, we obtained vaccine surveillance data from the Office for National Statistics, linked with COVID-19 vaccination status from the National Immunisation Management Service, England, from 8 Dec 2020 to 15 Feb 2021; data from 13,128,525 such women at population-level, were clustered by age (18-29, 30-39, and 40-49 years), self-defined ethnicity (19 UK government categories), and index of multiple deprivation (IMD, geographically-defined IMD quintiles). Here we show that among women of reproductive age, older age, White ethnicity and being in the least-deprived index of multiple deprivation are each independently associated with higher vaccine uptake, for first and second doses; however, ethnicity exerts the strongest influence (and IMD the weakest). These findings should inform future vaccination public messaging and policy.
| Item Type: | Article | ||||||
|---|---|---|---|---|---|---|---|
| Additional Information: | Correction available at https://doi.org/10.1038/s41467-023-41366-8 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2023, corrected publication 2023 | ||||||
| Keywords: | Pregnancy, Humans, Female, Adolescent, COVID-19 Vaccines, COVID-19, England, Ethnicity, Reproduction, Vaccination, RESILIENT Study Group, Humans, Vaccination, Reproduction, Pregnancy, Adolescent, England, Female, COVID-19, COVID-19 Vaccines, Ethnicity, Adolescent, COVID-19, COVID-19 Vaccines, England, Ethnicity, Female, Humans, Pregnancy, Reproduction, Vaccination | ||||||
| SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | ||||||
| Journal or Publication Title: | Nat Commun | ||||||
| ISSN: | 2041-1723 | ||||||
| Language: | eng | ||||||
| Dates: |
|
||||||
| Publisher License: | Creative Commons: Attribution 4.0 | ||||||
| Projects: |
|
||||||
| PubMed ID: | 36813760 | ||||||
| Web of Science ID: | WOS:001026242700001 | ||||||
 |
Go to PubMed abstract | ||||||
| URI: | https://openaccess.sgul.ac.uk/id/eprint/115684 | ||||||
| Publisher's version: | https://doi.org/10.1038/s41467-023-36125-8 |
Statistics
Actions (login required)
 |
Edit Item |